These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6404619)

  • 1. Pharmaceutical considerations of nitroglycerin.
    Yacobi A; Amann AH; Baaske DM
    Drug Intell Clin Pharm; 1983 Apr; 17(4):255-63. PubMed ID: 6404619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets.
    Nix DE; Tharpe WN; Francisco GE
    Am J Hosp Pharm; 1984 Sep; 41(9):1835-7. PubMed ID: 6437222
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis, disposition and pharmacokinetics of nitroglycerin.
    Curry SH; Aburawi SM
    Biopharm Drug Dispos; 1985; 6(3):235-80. PubMed ID: 3929851
    [No Abstract]   [Full Text] [Related]  

  • 4. The availability of nitroglycerin from parenteral solutions.
    Roberts MS; Cossum PA; Galbraith AJ; Boyd GW
    J Pharm Pharmacol; 1980 Apr; 32(4):237-44. PubMed ID: 6103051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of intravenous nitroglycerin solutions.
    Scheife AH; Grisafe JA; Shargel L
    J Pharm Sci; 1982 Jan; 71(1):55-9. PubMed ID: 6799641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets.
    Baaske DM; Amann AH; Wagenknecht DM; Mooers M; Carter JE; Hoyt HJ; Stoll RG
    Am J Hosp Pharm; 1980 Feb; 37(2):201-5. PubMed ID: 6767400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer sorption of nitroglycerin and stability of molded nitroglycerin tablets in unit-dose packaging.
    Pikal MJ; Bibler DA; Rutherford B
    J Pharm Sci; 1977 Sep; 66(9):1293-7. PubMed ID: 409834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroglycerin adsorption to a combination polyvinyl chloride, polyethylene intravenous administration set.
    Schaber DE; Uden DL; McCoy HG
    Drug Intell Clin Pharm; 1985; 19(7-8):572-5. PubMed ID: 3928309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of nitroglycerin solutions in polyolefin and glass containers.
    Wagenknecht DM; Baaske DM; Alam AS; Carter JE; Shah J
    Am J Hosp Pharm; 1984 Sep; 41(9):1807-11. PubMed ID: 6437221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of nitroglycerin tablets in a unit of use pendant-type container.
    Shangraw RF; Dorsch B
    Contemp Pharm Pract; 1981; 4(3):132-6. PubMed ID: 10309437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of an inhalation aerosol of nitroglycerin.
    Contractor AM; Snyder JM; Fletcher HP; Shangraw RF
    J Pharm Sci; 1974 Jun; 63(6):907-11. PubMed ID: 4211920
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of stabilized nitroglycerin tablets in typical distribution and administration systems.
    Dorsch B; Shangraw R
    Am J Hosp Pharm; 1975 Aug; 32(8):795-808. PubMed ID: 807102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin sublingual tablets. I. Stability of conventional tablets.
    Fusari SA
    J Pharm Sci; 1973 Jan; 62(1):122-9. PubMed ID: 4630198
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitroglycerin stability: effects on bioavailability, assay and biological distribution.
    Sokoloski TD; Wu CC
    J Clin Hosp Pharm; 1981 Dec; 6(4):227-32. PubMed ID: 6802877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sublingual tablets with nitroglycerin complexed with beta-cyclodextrin or titrated with crosspovidone--technological approach.
    Centkowska K; Sznitowska M
    Acta Pol Pharm; 2008; 65(5):585-9. PubMed ID: 19051606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the kinetic assay of nitroglycerin in dosage forms.
    Yap SK; Rhodes CT; Fung HL
    Am J Hosp Pharm; 1975 Oct; 32(10):1039-42. PubMed ID: 811115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application.
    Treleano A; Wolz G; Brandsch R; Welle F
    Int J Pharm; 2009 Mar; 369(1-2):30-7. PubMed ID: 19027840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.